Diaphragm Dysfunction During Prolonged Mechanical Ventilation (DD-SRPR)

March 27, 2023 updated by: Assistance Publique - Hôpitaux de Paris

Determinants of the Recovery of Diaphragm Dysfunction in Patients With Prolonged Mechanical Ventilation

The transition to unassisted breathing after invasive ventilation often proves challenging. Persistent ventilator dependence predisposes patients to nosocomial complications and death and increases the economic burden of critical illness. Ventilator-dependence results from an imbalance between the load and capacity of the respiratory muscle pump. Patients who fail a trial of spontaneous breathing commonly exhibit excess respiratory loads secondary to weaning-induced pulmonary edema, atelectasis or dynamic hyperinflation. At the same time, many ventilator-dependent patients exhibit striking loss of respiratory pump capacity due to diaphragm dysfunction which predisposes to prolonged ventilator dependence. Diaphragm dysfunction is common in ventilated patients. By prolonging ventilator dependence it may be an important contributor to the poor long-term clinical and functional outcomes of survivors of critical illness. While some main risk factors for diaphragm dysfunction have been already described (diaphragm disuse induced by mechanical ventilation, sepsis, initial severity upon admission), the determinants of recovery of diaphragm dysfunction are unknown, as well it has not been elucidated whether diaphragm function can simply improve after the acute phase of ICU admission. Therefore, the goal of this study is to investigate the time course evolution of diaphragm function in patients exposed to prolonged duration of mechanical ventilation (i.e. in a weaning center) and to determine which factors are associated with an improvement of the diaphragm function leading to a safe mechanical ventilation discontinuation.

Study Overview

Status

Active, not recruiting

Detailed Description

In this prospective study, all patients admitted to the weaning center of Pitié-Salpêtrière Hospital to undertake a weaning program will be closely followed up to assess twice a week their diaphragm function. Only one experimental group will be constituted. Diaphragm function will be assessed with both 1) the phrenic nerves stimulation technique and 2) diaphragm ultrasound (thickness, thickening fraction). The time course evolution of the diaphragm function over the stay will be investigated and all potential factors involved in the change in diaphragm function will be determined.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75013
        • Pitié-Salpêtrière Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 years old;
  • Admission in weaning center;
  • Tracheostomy;
  • Ventilator dependence as defined by clinical intolerance criteria under spontaneous - breathing (Boles et al. ERJ 2017);
  • Oral consent

Exclusion Criteria:

  • Contre indication to the phrenic nerves stimulation technique (pace maker);
  • Impossible liberation from the ventilator (degenerative neuromuscular diseases; high level spinal injury);
  • Pregnancy;
  • No insurance coverage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Measurement of diaphragm function
Patients will be followed up from admission to weaning with twice a week a diaphragm function multimodal evaluation (ultrasound, phrenic nerves stimulation technique)
A bilateral magnetic stimulation induces a non voluntary diaphragm contraction and a drop in airway pressure that is measured.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients successfully liberated from the ventilator
Time Frame: After 7 days of spontaneous breathing
Liberation from the ventilator will be defined after 7 days of spontaneous
After 7 days of spontaneous breathing

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diaphragm function
Time Frame: Twice a week, up to 4 weeks
Diaphragm function will be defined as pressure generating capacity. In practice, it will be assessed by using the phrenic nerves stimulation technique. A bilateral magnetic stimulation of the phrenic nerves will be done and the drop in endotracheal pressure so generated will be measured (twitch pressure).
Twice a week, up to 4 weeks
Partial liberation from mechanical ventilation
Time Frame: During hospitalization in Intensive Care Unit (ICU), up to 4 weeks
Partial liberation from ventilation will be defined by spontaneous breathing without the ventilator through closed or opened tracheostomy collar for a period of time between 12 and 24 hours, the rest of the time, patients being under invasive or non invasive mechanical ventilation.
During hospitalization in Intensive Care Unit (ICU), up to 4 weeks
Proportion of patients with diaphragm dysfunction upon admission and upon discharge
Time Frame: From date of admission in ICU until the date of hospital discharge in ICU, assessed up to 4 weeks
Proportion of patients with diaphragm dysfunction will be the ratio of patients with diaphragm dysfunction over the total number of patients enrolled in the study. Diaphragm dysfunction will be defined as a twitch pressure (endotracheal pressure generated by magnetic stimulation) below 11 cmH2O.
From date of admission in ICU until the date of hospital discharge in ICU, assessed up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin DRES, MD, PhD, Assistance Publique - Hopitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2019

Primary Completion (Anticipated)

October 22, 2024

Study Completion (Anticipated)

October 22, 2024

Study Registration Dates

First Submitted

August 10, 2018

First Submitted That Met QC Criteria

September 18, 2018

First Posted (Actual)

September 19, 2018

Study Record Updates

Last Update Posted (Actual)

March 28, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • K171101J
  • 2017-A03091-52 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolonged Mechanical Ventilation

Clinical Trials on Measurement of diaphragm function

Subscribe